NDA (New Drug Application)
ANDA (Generic Application)
Track protection status across key markets to assess launch feasibility.
It is formulated by 1 pharmaceutical company such as ACLARIS. It is marketed under 1 brand name, including ESKATA. Available in 1 different strength, such as 40%, and administered through 1 route including SOLUTION;TOPICAL.
API availability: Loading API feasibility...
Licensing: 1 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
| Strength | Route of Administration | Companies | Latest Approval Date |
|---|
Patents approved by the FDA for the ingredient
|
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
|---|---|---|---|---|---|
| {"application_id":"80440","ingredient":"HYDROGEN PEROXIDE","trade_name":"ESKATA","family_id":"39dd5a0dc2f345acbbb6","publication_number":"US10098910B2","cleaned_patent_number":"10098910","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-04-21","publication_date":"2018-10-16","legal_status":"Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362"} | US10098910B2 Formulation | 16 Oct, 2018 | Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 | 21 Apr, 2035 | |
| {"application_id":"80457","ingredient":"HYDROGEN PEROXIDE","trade_name":"ESKATA","family_id":"39dd5a0dc2f345acbbb6","publication_number":"US10493103B2","cleaned_patent_number":"10493103","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-04-21","publication_date":"2019-12-03","legal_status":"Expired"} | US10493103B2 Formulation | 03 Dec, 2019 | Expired | 21 Apr, 2035 | |
| {"application_id":"80459","ingredient":"HYDROGEN PEROXIDE","trade_name":"ESKATA","family_id":"39dd5a0dc2f345acbbb6","publication_number":"US10729720B2","cleaned_patent_number":"10729720","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-04-21","publication_date":"2020-08-04","legal_status":"Granted"} | US10729720B2 Formulation | 04 Aug, 2020 | Granted | 21 Apr, 2035 | |
| {"application_id":"80456","ingredient":"HYDROGEN PEROXIDE","trade_name":"ESKATA","family_id":"39dd5a0dc2f345acbbb6","publication_number":"US9980983B2","cleaned_patent_number":"9980983","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-04-21","publication_date":"2018-05-29","legal_status":"Granted"} | US9980983B2 | 29 May, 2018 | Granted | 21 Apr, 2035 | |
| {"application_id":"80455","ingredient":"HYDROGEN PEROXIDE","trade_name":"ESKATA","family_id":"39dd5a0dc2f345acbbb6","publication_number":"US9675639B2","cleaned_patent_number":"9675639","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-07-04","publication_date":"2017-06-13","legal_status":"Granted"} | US9675639B2 Formulation | 13 Jun, 2017 | Granted | 04 Jul, 2035 |
Latest clinical trials and research studies for this ingredient
| NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
|---|
Manufacturing Locations
Unlock access to all suppliers of Hydrogen Peroxide
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.